As of June 30, 2026, UCB S.A. carries a market capitalization of 57.16B, placing it among publicly traded companies globally. Its enterprise value stands at 59.90B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 57.16B |
| Enterprise Value | 59.90B |
UCB S.A.'s next confirmed earnings release is scheduled for February 25, 2027.
| Earnings Date | 2/25/2027 |
As of June 30, 2026, UCB S.A. has 381.61M shares outstanding.
| Shares Outstanding | 381.61M |
These figures are as of June 30, 2026.
| PB Ratio | 4.29 |
| P/TBV Ratio | 110.93 |
As of June 30, 2026, UCB S.A. maintains a current ratio of 1.20, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 1.20 |
| Quick Ratio | 0.26 |
| Debt / Equity | 30.79 |
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 10,117.00 |
As of the close on October 22, 2026, UCB S.A.'s stock has gained approximately 1.29% over the past 52 weeks. The 50-day moving average sits at 121.14, while the 200-day moving average is 139.89.
| 52-Week Price Change | 1.29% |
| 50-Day Moving Average | 121.14 |
| 200-Day Moving Average | 139.89 |
As of June 30, 2026, UCB S.A. holds 1.36B in cash and equivalents against 4.10B in total debt, resulting in a net debt position of 2.99B. Total book value stands at 13.31B, with working capital of 1.05B providing operational flexibility.
| Cash & Cash Equivalents | 1.36B |
| Total Debt | 4.10B |
| Net Debt | 2.99B |
| Equity (Book Value) | 13.31B |
| Book Value Per Share | 34.89 |
| Working Capital | 1.05B |
Already premium?